Servier
Generated by Meeveem AI
"Independent pharmaceutical group developing brand-name and generic medicines"
About Servier
Servier is an independent pharmaceutical group governed by a non-profit foundation and headquartered in Suresnes, France. Founded in 1954, it develops medicines in oncology, cardiometabolism and venous diseases, and neurology, including rare neurological disorders. Its medicines reach more than 130 countries.
The group reported 22,035 employees in 2024/25 and invests close to 20% of revenue from brand-name medicines in research and development. Its research network includes the Paris-Saclay R&D Institute and academic and industrial partnerships. Alongside acquisitions in rare oncology, Servier launched Servier Ventures in 2026 to invest in biotechnology and technology companies working on oncology and neurology.
Professional development
Servier describes a corporate university covering digital and data, leadership and management, and project management. Its development offer also includes mentoring, internal networks and opportunities for mobility and career progression.
Research partnerships
The group reported more than 60 research partnerships and collaborations in 2024/25, within a network of over 300 academic and industrial partners worldwide. Its Paris-Saclay institute also hosts Spartners by Servier & BioLabs, an incubator for young therapeutic-innovation companies.
22035
Team Members
1954
Founded
Pharma
Sector
Hybrid
Work Environment